SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-043680
Filing Date
2023-08-21
Accepted
2023-08-21 16:02:04
Documents
13
Period of Report
2023-08-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20230817.htm   iXBRL 8-K 63800
2 EX-3.1 allk-ex3_1.htm EX-3.1 362364
  Complete submission text file 0000950170-23-043680.txt   585493

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20230817_lab.xml EX-101.LAB 13351
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20230817_pre.xml EX-101.PRE 9838
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20230817.xsd EX-101.SCH 2466
7 EXTRACTED XBRL INSTANCE DOCUMENT allk-20230817_htm.xml XML 4694
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 231189104
SIC: 2834 Pharmaceutical Preparations